Gondré-Lewis, M.C.; Elman, I.; Alim, T.; Chapman, E.; Settles-Reaves, B.; Galvao, C.; Gold, M.S.; Baron, D.; Kazmi, S.; Gardner, E.;
et al. Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms? Biomedicines 2022, 10, 870.
https://doi.org/10.3390/biomedicines10040870
AMA Style
Gondré-Lewis MC, Elman I, Alim T, Chapman E, Settles-Reaves B, Galvao C, Gold MS, Baron D, Kazmi S, Gardner E,
et al. Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms? Biomedicines. 2022; 10(4):870.
https://doi.org/10.3390/biomedicines10040870
Chicago/Turabian Style
Gondré-Lewis, Marjorie C., Igor Elman, Tanya Alim, Edwin Chapman, Beverlyn Settles-Reaves, Carine Galvao, Mark S. Gold, David Baron, Shan Kazmi, Eliot Gardner,
and et al. 2022. "Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?" Biomedicines 10, no. 4: 870.
https://doi.org/10.3390/biomedicines10040870
APA Style
Gondré-Lewis, M. C., Elman, I., Alim, T., Chapman, E., Settles-Reaves, B., Galvao, C., Gold, M. S., Baron, D., Kazmi, S., Gardner, E., Gupta, A., Dennen, C., & Blum, K.
(2022). Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms? Biomedicines, 10(4), 870.
https://doi.org/10.3390/biomedicines10040870
